Shares News

GlaxoSmithKline rejects Unilever’s £50 billion offer for its consumer healthcare business as bidding war intensifies featured picture

GlaxoSmithKline rejects Unilever’s £50 billion offer for its consumer healthcare business as bidding war intensifies

Shares in pharmaceutical giant GlaxoSmithKline (GSK) shot to the top of the FTSE 100 leaderboard on Monday, gaining 5% to £17.19 after the company revealed it had received three unsolicited offers from Unilever (ULVR) for its consumer healthcare division. The latest proposal was received on 20 December and valued the division at £50 billion, comprised of £41.7 billion in cash and the ...
Showing 1 to 10 of 10,390